Teva Pharmaceutical Industries has unveiled authorized generic of Actos (pioglitazone-hydrochloride tablets) 15mg, 30mg and 45mg in the US.
Actos is marketed by Takeda Pharmaceuticals USA and used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes.
According to IMS sales data as of 30 June 2012, the brand product had annual sales of approximately $2.7bn in the US.
Diabetes mellitus type 2 is a metabolic disorder that is characterized by high blood glucose in the context of insulin resistance and relative insulin deficiency.
The disorder is in contrast to diabetes mellitus type 1 in which there is an absolute insulin deficiency due to destruction of islet cells in the pancreas.
Source:
http://drugdiscovery.pharmaceutical-business-review.com/news/teva-unveils-generic-actos-in-us-200812
